Connealy Pamela Ann 4
4 · Pyxis Oncology, Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Connealy Pamela Ann
CFO & COO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-31$0.98/sh+414,163$405,880→ 414,163 totalExercise: $0.98Exp: 2035-03-31→ Common Stock (414,163 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31, 2025 and the remainder vesting in 36 equal monthly installments thereafter subject to the reporting person's continued emmployment through the applicable vesting date.